Related Experiment Video

Updated: Aug 21, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Risk of drug-induced congenital defects

Marco De Santis1, Gianluca Straface, Brigida Carducci

  • 1Telefono Rosso-Teratology Information Service, Institute of Obstetrics and Gynaecology, Catholic University Sacred Heart, Largo A. Gemelli 8, Rome 00168, Italy. marcodesantis@rm.unicatt.it

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|October 12, 2004
PubMed

Insights

Preventing drug-induced birth defects involves cautious medication use in women of childbearing potential. Strict medical supervision and knowledge of drug teratogenicity are crucial for safe pregnancy outcomes.

Area of Science:

  • Medical Science
  • Pharmacology
  • Teratology

Background:

  • Drug therapy accounts for approximately 1% of congenital defects with known causes.
  • A significant number of pregnancies are unplanned, highlighting the need for proactive measures.
  • The number of drugs with known teratogenic effects is substantial, with ongoing development of new pharmaceuticals.

Purpose of the Study:

  • To emphasize the importance of a precautionary approach to drug use in women of reproductive age.
  • To underscore the complexity in recognizing drug-induced teratogenic effects.
  • To advocate for informed medication management during pregnancy and preconception.

Main Methods:

  • Review of existing data on drug-induced teratogenicity.
  • Consideration of both animal experimental data and human experience.
  • Highlighting the role of Teratology Information Services.

Main Results:

  • Approximately 25 drugs currently have proven teratogenic effects, with more in development.
  • Recognition of teratogenicity requires a multifaceted approach, integrating diverse data sources.
  • Strict medical control is essential for drugs with known or suspected teratogenic potential, especially in unplanned pregnancies.

Conclusions:

  • Judicious drug use in fertile and pregnant women is a viable preventive strategy for congenital defects.
  • Informed therapeutic decisions, including pre-conception therapy modification, are vital.
  • Prioritizing essential medications with available clinical data and utilizing Teratology Information Services can mitigate risks.

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...